I kēia mau lā iho nei, ua ʻāpono ka National Medical Products Administration (NMPA) o Kina iā Enhertu no ka inikini no ka mālama ʻana i nā ʻano maʻi kikoʻī me ka maʻi ʻaʻai umauma holomua, e hōʻailona ana i kahi holomua koʻikoʻi i ka hakakā honua e kūʻē i ka maʻi ʻaʻai umauma. Hoʻokumu ʻia kēia ʻāpono ma nā hopena maikaʻi o ka hoʻokolohua lapaʻau DESTINY-Breast06, e hōʻike ana i kahi holomua no ka lāʻau lapaʻau kikoʻī i kuhikuhi ʻia i ka hormone receptor-positive,
Ma Dekemaba 25, 2025, ua ʻae kūhelu ʻo NMPA iā Enhertu no ka mālama ʻana i nā poʻe maʻi kanesa umauma makua me ka inoperable a metastatic hormone receptor-positive, HER2-low a i ʻole ultra-low expression i holomua ma hope o ka endocrine therapy mua ma ke ʻano metastatic. Ua ʻōlelo ʻo Polofesa Hu Xichun, Luna Hoʻokele o ka 'Oihana Lapaʻau Kūloko ma ke Kulanui ʻo Fudan Shanghai Cancer Center: "Hāʻawi nā hopena o ke aʻo ʻana ʻo DESTINY-Breast06 i ka hōʻike mua e hiki i ka precision targeted therapy ke pōmaikaʻi i kēia heluna kanaka maʻi i lawelawe ʻole ʻia ma mua, he mea nui ia i ka ʻepekema. Me kēia ʻae ʻia, ʻoi aku ka nui o nā poʻe maʻi kanesa umauma holomua HR-positive me ka hōʻike ʻana o HER2 e loaʻa ka manawa kūpono e pōmaikaʻi ai mai ka lāʻau lapaʻau ADC."
He mea hoʻoikaika ka ʻikepili hoʻokolohua lapaʻau: no nā poʻe maʻi kanesa umauma metastatic HR-positive, HER2-low i loaʻa ʻole i ka chemotherapy ma mua, ua hoʻemi ʻo Enhertu i ka pilikia o ka holomua o ka maʻi a i ʻole ka make ma 38% i hoʻohālikelike ʻia me ka chemotherapy. ʻOi aku ka mea nui, ua hōʻea ka helu pane pahuhopu i 56.5% i nā poʻe maʻi HER2-low a hiki i ka 61.8% i ka heluna kanaka HER2 ultra-low expression, ʻoi aku ka kiʻekiʻe ma mua o ka hui chemotherapy.
ʻOihana Hoʻokele Honua o ka Halemai Oncology o ka ʻĀpana Hema o Beijing: Hoʻohui i nā Maʻi Honua me ka Lapaʻau Kiʻekiʻe
Ma ke ʻano he hoʻokahi o nā kikowaena lapaʻau oncology koʻikoʻi o Kina, ua hoʻolaʻa ʻia ka Beijing South Region Oncology Hospital International Department i ka hāʻawi ʻana i nā poʻe maʻi honua me nā koho lapaʻau maʻi kanesa holomua loa a me nā lawelawe lapaʻau pilikino. Ke hahai pono nei mākou i ka holomua o ka lāʻau lapaʻau honua e hōʻoia i hiki i nā poʻe maʻi ke komo koke i nā lāʻau lapaʻau i ʻae ʻia.
ʻO kā mākou hui lapaʻau honua he poʻe loea oncology akamai i ʻike ʻole ʻia i nā ʻenehana lapaʻau hou loa akā loaʻa iā lākou nā mākau kamaʻilio multilingual, e hiki ai iā lākou ke hāʻawi i ke kākoʻo lapaʻau piha a me nā lawelawe i nā poʻe maʻi o ka honua.
Nā Kaila Hoʻokaʻaʻike Kūpono: Nā Ala He Nui no ke Kūkākūkā ʻana
Hoʻomaopopo mākou i nā pono wikiwiki o nā maʻi o ka honua e ʻimi nei i ke kōkua lapaʻau, no laila ke hāʻawi aku nei mākou i nā ʻano hana hoʻopili kūpono like ʻole:
Kūkākūkā Kelepona: E ʻoluʻolu e kelepona i kā mākou laina kōkua hoʻomanawanui honua ma 400-880-3716. E hāʻawi aku kā mākou mau luna hoʻonohonoho lapaʻau ʻoihana iā ʻoe i ke kūkākūkā kikoʻī a me ke alakaʻi.
Hoʻokaʻaʻike WeChat: E hoʻohui i kā mākou moʻokāki WeChat kūhelu ma 17801183037 e kamaʻilio pololei me kahi kākāʻōlelo lapaʻau ma o ka leka uila, leo, a i ʻole wikiō.
Leka uila:
- Send inquiries to 100085_010@163.com
- Or contact myimmnet@163.com
E pane aku kā mākou hui i kāu leka uila i loko o 24 mau hola, e hāʻawi iā ʻoe i ka ʻike kikoʻī e pili ana i ka lāʻau lapaʻau, nā hoʻolauna haukapila, nā manawa loea, a me nā lawelawe ʻē aʻe.
Nā lawelawe maʻi honua piha
Hāʻawi ka ʻOihana Hoʻokipa ʻOncology o ka ʻĀpana Hema ʻo Beijing i nā lawelawe kū hoʻokahi no nā poʻe maʻi o ka honua, me:
- Kūkākūkā loea a me nā kūkākūkā mamao
- Ka loiloi a me ka hoʻonohonoho ʻana o ka hoʻolālā lapaʻau
- Nā hoʻonohonoho hoʻokipa haukapila a me ke kākoʻo visa lapaʻau
- Kōkua i ka unuhi ʻōlelo a me ka hoʻololi ʻana i nā moʻomeheu
- Nā alakaʻi no nā hoʻonohonoho noho ʻana i ka wā o ka mālama ʻana
Hoʻomaopopo nui mākou he kū hoʻokahi ka huakaʻi a kēlā me kēia mea maʻi. No laila, ua kūpaʻa mākou i ka hāʻawi ʻana i nā lawelawe lapaʻau pilikino a lokomaikaʻi hoʻi e hōʻoia iā ʻoe e loaʻa ka mālama ʻoihana a me ke kākoʻo i ka wā o kāu mālama ʻana.
E Hana: E Loaʻa i ka ʻŌlelo Aʻo no ka Lapaʻau Pilikino
Inā ʻoe a i ʻole kāu poʻe aloha e kū nei i nā pilikia i ka mālama ʻana i ka maʻi ʻaʻai umauma, ʻoi aku hoʻi ka maʻi ʻaʻai umauma holomua o nā ʻano hōʻike HR-positive, HER2-low a i ʻole ultra-low, ʻo ia ka manawa e ʻimi ai i ka ʻōlelo aʻoaʻo lapaʻau loea. ʻO ka ʻae ʻia ʻana o Enhertu e lawe mai i ka manaʻolana hou i kēia hui maʻi.
E leka uila mai iā mākou koke ma o kēia mau ʻano hana:
- Kāhea iā 400-880-3716 e kamaʻilio pololei me ke kākā'ōlelo lapaʻau
- E hoʻohui iā WeChat 17801183037 no ke kūkākūkā koke ʻana
- Send an email to 100085_010@163.com or myimmnet@163.com with a detailed description of the condition
E hāʻawi kā mākou hui lapaʻau honua i nā ʻōlelo aʻoaʻo lapaʻau ʻoihana a me ka hoʻolālā e pili ana i kou kūlana kikoʻī. Ma ka ʻOihana Hoʻokipa ʻOncology o ka Halemai ʻo Beijing South Region, ke manaʻoʻiʻo nei mākou he pono i kēlā me kēia mea maʻi ke komo i ka lāʻau lapaʻau holomua a kūpono hoʻi. Ke kakali nei mākou e kōkua iā ʻoe ma ke ala e hoʻōla ai.
Ka manawa hoʻouna: Ian-08-2026